Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Sumitomo Aiming to Take the Lead in Developing Universal Flu Vaccines
October 19, 2022
-
BUSINESS Bayer to Distribute Xarelto Tablets 2.5 mg via Single Wholesaler
October 18, 2022
-
REGULATORY Health Ministry Research Team to Vet Recall Rules to Address Supply Disruptions
October 17, 2022
-
BUSINESS Fujifilm Ditches Avigan COVID-19 Program, Pulls Submission in Japan
October 17, 2022
-
BUSINESS Fertility Drugs Face Supply Woes as Demand Spikes on Health Coverage
October 14, 2022
-
REGULATORY Govt Eyes Designation of Cefazolin, Other Antibiotics as Key Resources
October 14, 2022
-
REGULATORY MHLW Expert Panel Sorts Out Discussion Points for Full Debate; Focus on Innovation, Stable Supply, and Margins
October 13, 2022
-
ACADEMIA Japan Expert Sees Lecanemab Initially Treating Only a Few Tens of Thousands of Patients with Immature Care Setup
October 12, 2022
-
BUSINESS Kyushu Univ. Spinoff Aims to File NK-Like Cells in 2025, Eyes Combo with Checkpoint Drugs
October 11, 2022
-
REGULATORY Japan to Roll Out BA.4/5 Omicron Boosters on Oct. 13, Inoculations for 6 Months to 4 Years from Oct. 24
October 11, 2022
-
REGULATORY MHLW Panel to Discuss Shortening of COVID Booster Interval
October 11, 2022
-
ORGANIZATION EFPIA Chief Prods Japan on Mutual Trial Data Recognition, Cooperation to Boost Attractiveness to Rival US, China
October 7, 2022
-
REGULATORY Chuikyo Kicks Off Debate on FY2023 Off-Year Drug Price Revision
October 6, 2022
-
BUSINESS Moderna Files BA.4/5-Tailored COVID-19 Vaccine in Japan
October 5, 2022
-
REGULATORY Japan Panel OKs Inclusion of Silgard 9 into National Immunization Program
October 5, 2022
-
BUSINESS Novartis Homes in on 5 Therapy Areas and 4 Markets, Eyes Top 3 Multinational Rank in Japan: CEO
October 4, 2022
-
BUSINESS Celltrion Aims to Market 11 Biosimilars in Japan, Infliximab “Biobetter” in the List
October 3, 2022
-
REGULATORY Japan Ends Supply of AstraZeneca’s COVID Jab, 13.5 Million Doses Discarded
October 3, 2022
-
REGULATORY Wholesalers Question Inflexibility in Official Pricing, Sees Limit to Addressing Rising Costs
September 30, 2022
-
BUSINESS Ferring Japan CEO Confident of Growth in Fertility Drugs Spurred by Rising Demand on Health Coverage
September 30, 2022
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…